• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症症状管理

Multiple sclerosis symptom management.

作者信息

Boissy Adrienne R, Cohen Jeffrey A

机构信息

Cleveland Clinic Foundation, Mellen Center U-10, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Expert Rev Neurother. 2007 Sep;7(9):1213-22. doi: 10.1586/14737175.7.9.1213.

DOI:10.1586/14737175.7.9.1213
PMID:17868019
Abstract

Multiple sclerosis (MS) is the most common cause of nontraumatic disability in young adults. The increasing emphasis on early treatment with disease-modifying therapies has the goal of preventing long-term disability. However, current disease treatments are only partially effective, and most patients experience a variety of neurologic symptoms at various times during their disease course. Because these symptoms often have a profound impact on social, occupational and physical performance, effective symptom management is an important component of therapy to maintain quality of life. Effective symptom management often requires a multidisciplinary team approach. This review outlines general principles of the management of MS symptoms.

摘要

多发性硬化症(MS)是年轻成年人非创伤性残疾的最常见原因。越来越强调使用疾病修正疗法进行早期治疗,目标是预防长期残疾。然而,目前的疾病治疗仅部分有效,大多数患者在病程中的不同时间会出现各种神经症状。由于这些症状通常对社交、职业和身体表现有深远影响,有效的症状管理是维持生活质量的治疗的重要组成部分。有效的症状管理通常需要多学科团队方法。本综述概述了MS症状管理的一般原则。

相似文献

1
Multiple sclerosis symptom management.多发性硬化症症状管理
Expert Rev Neurother. 2007 Sep;7(9):1213-22. doi: 10.1586/14737175.7.9.1213.
2
Symptomatic management in multiple sclerosis.多发性硬化的症状管理。
Neurol Clin. 2011 May;29(2):449-63. doi: 10.1016/j.ncl.2011.01.008.
3
Managing the symptoms of multiple sclerosis: a multimodal approach.多发性硬化症症状的管理:一种多模式方法。
Clin Ther. 2006 Apr;28(4):445-60. doi: 10.1016/j.clinthera.2006.04.005.
4
Symptom management.症状管理。
Adv Neurol. 2006;98:227-55.
5
[Symptomatic therapies for multiple sclerosis].[多发性硬化症的对症治疗]
Nihon Rinsho. 2003 Aug;61(8):1355-60.
6
The place of the botulinum toxin in the management of multiple sclerosis.肉毒杆菌毒素在多发性硬化症治疗中的作用
Clin Neurol Neurosurg. 2010 Sep;112(7):592-6. doi: 10.1016/j.clineuro.2010.04.010. Epub 2010 Jul 8.
7
[Spasticity in multiple sclerosis].[多发性硬化症中的痉挛状态]
Clin Ter. 2004 Apr;155(4):135-8.
8
Therapeutics for multiple sclerosis symptoms.多发性硬化症症状的治疗方法。
Mt Sinai J Med. 2011 Mar-Apr;78(2):176-91. doi: 10.1002/msj.20245.
9
Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.识别、病因分析、缓解及预防并发症(ICAP):一种多发性硬化症症状及残疾管理方法
Neurology. 2008 Dec 9;71(24 Suppl 3):S14-20. doi: 10.1212/WNL.0b013e31818f3da5.
10
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].[多发性硬化症中痉挛状态的流行病学与临床评估]
Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S45-50. doi: 10.1016/S0035-3787(12)70046-2.

引用本文的文献

1
Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis.天然产物在多发性硬化症动物模型中对抗氧化应激的潜在效用
Antioxidants (Basel). 2022 Jul 29;11(8):1495. doi: 10.3390/antiox11081495.
2
Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.多发性硬化症的补充和替代疗法:系统文献分类和分析。
Acta Neurol Belg. 2022 Apr;122(2):281-303. doi: 10.1007/s13760-021-01847-3. Epub 2022 Jan 21.
3
Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis.
星形胶质细胞和小胶质细胞嘌呤能 P2X7 受体在多发性硬化症病程中的神经炎症中的主要贡献者。
Int J Mol Sci. 2021 Aug 5;22(16):8404. doi: 10.3390/ijms22168404.
4
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System.治疗中枢神经系统自身免疫性疾病的纳米技术新方法
Brain Sci. 2020 Jun 2;10(6):338. doi: 10.3390/brainsci10060338.
5
Contraceptive use among women with multiple sclerosis: a systematic review.多发性硬化症女性的避孕措施使用情况:一项系统综述
Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21.
6
The multiple sclerosis self-management scale: clinicometric testing.多发性硬化自我管理量表:临床计量学测试
Int J MS Care. 2014 Summer;16(2):61-7. doi: 10.7224/1537-2073.2013-019.
7
Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.多发性硬化症中神经性疼痛的机制与药理学
Curr Top Behav Neurosci. 2014;20:75-97. doi: 10.1007/7854_2014_288.
8
[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].[4-氨基吡啶(法吡拉定)。多发性硬化对症治疗的新尝试]
Nervenarzt. 2010 Feb;81(2):203-11. doi: 10.1007/s00115-009-2902-2.